PHS
CGEM icon

PFM Health Sciences’s Cullinan Oncology CGEM Stock Holding History

PFM Health Sciences’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.23M Buy
227,406
+403
+0.2% +$5.18K 0.29% 73
2025
Q4 		$2.35M Buy
+227,003
New +$2.05M 0.23% 67
2024
Q4 		– Sell
-182,810
Closed -$3.06M – 89
2024
Q3 		$3.06M Sell
182,810
-113,226
-38% -$2.01M 0.17% 59
2024
Q2 		$5.16M Buy
296,036
+40,069
+16% +$853K 0.26% 59
2024
Q1 		$4.36M Buy
+255,967
New +$3.96M 0.21% 71

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PFM Health Sciences's CGEM Position: Q1 2026 in Review

PFM Health Sciences increased its Cullinan Oncology (CGEM) stake by 0.18% in Q1 2026, buying an estimated $5.18K and bringing the position to 227,406 shares worth $3.23M. The position accounts for 0.29% of the portfolio, ranked #73.

PFM Health Sciences first reported a position in CGEM in Q1 2024 and has held it in 5 quarters since. The position peaked at $5.16M in Q2 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • PFM Health Sciences held 227,406 shares of Cullinan Oncology worth $3.23M as of Q1 2026.
  • PFM Health Sciences bought 403 Cullinan Oncology shares in Q1 2026, an estimated $5.18K.
  • Cullinan Oncology made up 0.29% of PFM Health Sciences's portfolio in Q1 2026, its #73 holding.
  • PFM Health Sciences first reported a position in Cullinan Oncology in Q1 2024 and has held it in 5 quarters since.
  • PFM Health Sciences's Cullinan Oncology position peaked at $5.16M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.